31431 Tirzepatide for Sale
Compare supplier listings for Tirzepatide (CAS 2023788-19-2) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Premium Research Grade Tirzepatide Bioactive Powder CAS 2023788-19-2 Stable Quality for Endocrine Lab Assays
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials
Lab Grade Tirzepatide CAS 2023788-19-2 Consistent Pure White Peptides Powder
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials
Tirzepatide CAS 2023788-19-2 Research Grade Bioactive peptides Powder, consistent purity for endocrine receptor binding biochemical assays.
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg*10vials
Tirzepatide CAS 2023788-19-2 Research Grade Bioactive Peptide Powder with Consistent Purity for Endocrine Receptor Binding Assays
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials
Tirzepatide CAS 2023788-19-2 High Quality Peptides Powder 5mg 10mg 15mg Vial GMP Certified Fast Delivery Research Use Only for Lab Experiments
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
30mg*10vials
Products You May Be Interested in
Tirzepatide CAS 2023788-19-2 Lab Grade Regulatory peptides, sealed sterile vials with complete COA for global academic lab logistics support.
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
30mg*10vials
Tirzepatide CAS 2023788-19-2 High Purity Peptides Raw Material 10mg/20mg Vial Lyophilized Form for Laboratory Research & Development Use Only
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
40mg*10vials
Tirzepatide CAS 2023788-19-2 GIP GLP-1 Receptor Agonist High Purity Lyophilized Powder 5mg 10mg Vial Research Use Only Lab Grade Raw Material
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials
Tirzepatide CAS 2023788-19-2 Dual Receptor Synthetic peptides 99% Lyophilized Powder, lab reagent for endocrine cell in vitro laboratory research
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
40mg*10vials
Tirzepatide CAS 2023788-19-2 Purity Lyophilized Peptides 2mg 5mg 10mg Vial Factory Wholesale Research Use Only for Life Science Research
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
15mg*10vials
About Tirzepatide List
- Buying Tirzepatide on www.echemi.com where you will find large variety of good choices. Suppliers of 31431 Tirzepatide registered will be verified by the accurate information. Safe transaction of chemical will be made based on true information. We help you get chemicals in need continuously and meet registered Tirzepatide suppliers.
- The quality of Tirzepatide 2023788-19-2 will be secured by ECHEMI. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. Tirzepatide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. You can enjoy the chemical supply chain services on ECHEMI. We will help you purchase Tirzepatide and run fast your business.
Check Out More Resources
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide